Sorting by

×

Exhibit: Sexually Transmitted Diseases and Infections

Exhibit: Sexually Transmitted Diseases and Infections

Syphilis
Gonorrhea
Chlamydia

FDA Approves Two Oral Therapies to Treat Gonorrhea

“The availability of additional treatment options is of particular importance given the global rise in gonococcal drug resistance,” – Peter Kim, M.D., M.S., director of the Center for Drug Evaluation and Research (CDER) Division of Anti-infectives

Human Papillomavirus and Cancer

Globally, it is estimated that 620,000 new cancer cases in women and 70,000 new cancer cases in men were caused by HPV in 2019. Cervical cancer was the fourth leading cause of cancer and cancer deaths in women in 2022, with some 660 000 new cases and around 350 000 deaths worldwide. Cervical cancers account for over 90% of HPV-related cancers in women.

There is currently no treatment for HPV infection. 

A bottle of Salvarsan, a treatment for Syphilis, and the first commercial treatment developed for an STD over 100 years ago. It was the first modern anti-microbial agent.
Entries in German scientist Paul Ehrlich’s laboratory notebook illustrating the development of Salvarsan

Purchase a piece of history: The Collected Papers of Paul Ehrlich, Volumes 1, 2, and 3. Now available through our artifact sales department.

In this exhibit we have used dates that the sources themselves have used. In most cases that is CE, Christian-based dating. Religion has had a long history in healthcare, and that history may be visited in another exhibit, but outside of a museum we believe religious dating is a thing of the past. This exhibit incorporates science and research that is at the cutting edge, and this is an opportunity to move forward with awareness that many institutions are still operating using religious dating rather than a science-based system.